Maribao, Kim Estila L.
HRN: 25-79-04 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2025
CEFTRIAXONE 1G (VIAL)
12/14/2025
12/20/2025
IV DRIP
1.5g
OD
PCAP
Checking Final Appropriateness
12/18/2025
CEFTAZIDIME 1GM (VIAL)
12/18/2025
12/24/2025
IVT
750mg
Q8
Sepsis
Checking Final Appropriateness